Theralizumab
Originally intended for the treatment of B cell chronic lymphocytic leukemia ( B-CLL ) and rheumatoid arthritis , TGN1412 is a humanised monoclonal antibody that not only binds to , but is a strong agonist for , the CD28 receptor of the immune system's T cells . 
<triplet> T cell <subj> immune system <obj> part of